Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives by Mozaffarian N, Lobosco S, Lu P, Roughley A, Alperovich G

Get full text

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase... by Mease, P, Coates, L, Helliwell, P, Stanislavchuk, M, Rychlewska-Hanczewska, A, Dudek, A, Abi-Saab, W, Tasset, C, Meuleners, L, Harrison, P, Besuyen, R, Van Der Aa, A, Mozaffarian, N, Greer, J, Kunder, R, Van Den Bosch, F, Gladman, D